IT - EN
News & Announcements

News & AnnouncementsBusiness & financial news

2019, September 5 ARRIGO RECORDATI INTERNATIONAL PRIZE FOR SCIENTIFIC RESEARCH AWARDED TO ALBERTO AURICCHIO
2019, July 30 - 13:10 RECORDATI ANNOUNCES GROWTH IN THE FIRST HALF 2019. REVENUES +6.8%, EBITDA +7.4%, NET INCOME +6.1%
2019, July 12 - 20:15 RECORDATI TO ACQUIRE WORLDWIDE RIGHTS TO SIGNIFOR® AND OSILODROSTAT (LCI699)
2019, June 24 RECORDATI RARE DISEASES, A WORLDWIDE LEADER IN RARE DISEASES AND ORPHAN DRUGS
2019, May 8 - 12:24 RECORDATI ANNOUNCES GROWTH IN THE FIRST QUARTER 2019. NEW THREE YEAR BUSINESS PLAN APPROVED
2019, April 15 - 09:06 RECORDATI TO MEET WITH THE FINANCIAL COMMUNITY
2019, April 11 - 14:38 RECORDATI SHAREHOLDERS APPROVE THE 2018 ACCOUNTS. DIVIDEND € 0.92 PER SHARE (+8.2% vs 2017)
2019, February 28 - 15:08 RECORDATI: BOARD APPROVES THE 2018 ACCOUNTS. SALES € 1,352.2 MILLION (+5.0%), EBITDA € 499.1 MILLION (+9.8%), OPERATING INCOME € 442.2 MILLION (+8.8%) AND NET INCOME € 312.4 MILLION (+8.2%). 2018 DIVIDEND € 0.92 (+8.2%)
2019, February 11 - 12:54 RECORDATI: PRELIMINARY 2018 RESULTS CONFIRM CONTINUED GROWTH OF SALES AND PROFITABILITY. SALES +5.0%, EBITDA +9.8%, OPERATING INCOME +8.8%, NET INCOME +8.2%.
2019, February 6 RECORDATI OBTAINS EXCLUSIVE LICENSE FOR JUXTAPID® IN JAPAN
2019, February 5 RECORDATI: SHAREHOLDERS APPOINT THE NEW BOARD OF DIRECTORS. THE BOARD OF DIRECTORS APPOINTS FLEMMING ØRNSKOV AS CHAIRMAN AND CONFIRMS ANDREA RECORDATI AS CHIEF EXECUTIVE OFFICER
2019, January 28 RECORDATI: 2019 CORPORATE EVENTS' CALENDAR
2019, January 7 Press release on behalf of FIMEI S.p.A. - New Recordati Board members proposed by majority shareholder FIMEI, including Dr. Flemming Ørnskov as Chairman designate
= price sensitive (as from 2015)